Preparation of Carbohydrate-Protein Conjugates
crude reaction mixture was diluted with CH2Cl2 and washed
with 0.1 N aq HCl and then brine. The organic layer was dried
over anhydrous Na2SO4, filtered, and concentrated under
reduced pressure. The crude residue was purified by chroma-
tography on silica gel (cyclohexane/EtOAc 7:3) to give the
succinimidyl ester 21 (400 mg, 63%) as an oil: Rf ) 0.32
(EtOAc/cyclohexane 4:6); 1H NMR (400 MHz, CDCl3) δ 7.76-
7.70 (m, 4 H), 7.58-7.45 (m, 6 H), 3.74 (d, 2 H, J ) 6.6 Hz),
2.86 (br s, 4 H, 2 CH2), 2.62 (t, 2 H, J ) 7.2 Hz), 2.50 (t, 2 H,
J ) 7.4 Hz), 1.95 (q, 2 H, J ) 7.3 Hz), 1.51-0.52 (br m, 3 H);
13C NMR (100 MHz, CDCl3) δ 196.0, 169.3 (2 C), 168.1, 133.0
(d, 4 C, J ) 9.4 Hz), 132.2 (d, 2 C, J ) 2.3 Hz), 129.2 (d, 4 C,
J ) 10.1 Hz), 127.8 (d, J ) 55.4 Hz), 42.1, 30.0, 26.0 (2 C),
23.8 (d, J ) 35.2 Hz), 20.7; 31P NMR (162 MHz, CDCl3) δ 20.73
(d, J ) 64.3 Hz); positive CI-MS m/z 475 [M + NH4]+, 444 [M
+ BH2]+; HRMS (FAB) calcd for [M + H - H2]+ 456.1210,
found 456.1200.
buffer saline, pH 7.3 (0.9-1.5 µL), was added the succinimidyl
ester 39, or 41 [3 × 10 equiv dissolved in CH3CN (50 µL)], in
three portions every 2 h. Following an additional reaction
period of 2 h, the crude reaction mixture was purified by RP-
HPLC (gradient: 0% B for 5 min then 0-30% B over 60 min).
The collected fractions were diluted with H2O, frozen, and
freeze-dried to give the corresponding activated-pmLPS 26, or
27, as a white foam. pmLPSC6N3 26 (8.5 mg, 38%) was
obtained as well as recovered starting material 35 (5.2 mg,
24%): (negative MALDI-TOF-MS) m/z 7197, 6951, 6702, 6455,
6207, 5960, 5713, 5466, 5219, 4970 (M - H)-, 7169, 6922, 6675,
6429, 6181, 5933, 5686, 5438, 5192 (M - N2 - H)- (22-mer to
14-mer). pmLPSC12N3 27 (7.3 mg, 58%) was obtained as well
as recovered starting material 35 (2.0 mg, 20%): (negative
MALDI-TOF-MS) m/z 7312, 7066, 6814, 6572, 6321, 6070 (M
- H)- (22-mer to 17-mer).
Derivatization of the Protein Carriers. In a typical
experiment, a stock solution of TT (18 mg, 820 µL, 0.12 µmol)
was diluted with 0.2 M potassium phosphate buffer saline, pH
7.3 (340 µL). To this solution was added succinimidyl 2-(diphe-
nylphosphanyl)phenyl glutarate 20 (3 × 2.61 mg dissolved in
50 µL of CH3CN) or the borane-phosphine complex 21 (3 ×
1.63 mg dissolved in 100 µL of CH3CN) in three portions every
2 h. Following an additional reaction period of 4 h, the crude
reaction mixtures were dialyzed against 0.1 M potassium
phosphate buffer, pH 6 (3 × 2 L over 2 days), at 4 °C to remove
excess reagent. Phosphino-functionalized TT 22 and 23 were
used without further purification.
Similarly, BSA (5 mg, 0.08 µmol) was diluted with 0.2 M
potassium phosphate buffer saline, pH 7.3 (340 µL). To this
solution was added the borane-phosphine complex 21 (3 ×
1.02 mg dissolved in 100 µL of CH3CN, 3 × 30 equiv), in three
portions every 2 h. Following an additional reaction period of
4 h, the crude reaction mixture was dialyzed against 0.1 M
potassium phosphate buffer, pH 6 (3 × 2 L over 2 days) at 4
°C to remove excess reagent. Phosphino-functionalized BSA
24 was used without further purification. The extent of
derivatization of these protein carriers was determined by
comparison of the SELDI-TOF mass spectra of compounds 22-
24 with those of their parent protein.
6-Azidohexanoic Acid 38. To a stirred solution of 6-bro-
mohexanoic acid (1.5 g, 7.7 mmol) in DMF (5 mL) was added
sodium azide (1.0 g, 15.4 mmol), and the mixture was heated
at 85 °C for 3 h. The crude reaction mixture was diluted in
CH2Cl2, and this solution washed with 0.1 N aq HCl. The
organic layer was dried over anhydrous Na2SO4, filtered, and
concentrated under reduced pressure to give 38 (1.0 g, 82%)
as an oil, which was used without further purification: Rf )
1
0.63 (EtOAc/CH2Cl2 3:7); H NMR (400 MHz, CDCl3) δ 11.00
(br s, 1 H), 3.29 (t, 2 H, J ) 6.9 Hz), 2.39 (t, 2 H, J ) 7.4 Hz),
1.73-1.58 (m, 4 H), 1.49-1.40 (m, 2 H); 13C NMR (100 MHz,
CDCl3) δ 180.3, 51.6, 34.2, 28.9, 26.5, 24.5; CI-MS m/z 175 [M
+ NH4]+.
6-Azidohexanoic Acid Succinimidyl Ester 39. To a
stirred solution of 6-azidohexanoic acid 38 (590 mg, 3.76 mmol,
1 equiv) and N-hydroxysuccinimide (432 mg, 3.76 mmol) in
CHCl3/DMF 9:1 (1 mL) was added EDC (720 mg, 3.76 mmol),
and the mixture stirred at rt overnight. The crude reaction
mixture was diluted with CH2Cl2 and washed with 1 N aq HCl,
5% aq NaHCO3, and then brine. The organic layer was dried
over anhydrous Na2SO4, filtered, and concentrated under
reduced pressure to give the succinimidyl ester 39 (760 mg,
80%) as an oil which was used without further purification:
1
Rf ) 0.76 (EtOAc/CH2Cl2 3:7); H NMR (400 MHz, CDCl3) δ
3.29 (t, 2 H, J ) 6.8 Hz), 2.82 (br s, 4 H), 2.62 (t, 2 H, J ) 7.4
Hz), 1.77 (q, 2 H, J ) 7.4 Hz), 1.68-1.56 (m, 2 H), 1.54-1.44
(m, 2 H); 13C NMR (100 MHz, CDCl3) δ 169.6 (2 C), 168.8,
51.5, 31.1, 28.8, 26.2, 26.0 (2 C), 24.5; CI-MS m/z 272 [M +
NH4]+. Anal. Calcd for C10H14N4O4: C, 47.24; H, 5.55; N, 22.04.
Found: C, 47.11; H, 5.55; N, 22.05.
Staudinger Ligation Procedures. Method A. Azido-
activated carbohydrate hapten 25, 26, or 27 was added in one
portion to the corresponding modified TT or BSA, 23 or 24,
respectively, in solution in DMF/aq NaCl 0.05 M 5/1, at a 20:1
molar ratio. DABCO (40 equiv) (at a 60 mg‚mL-1 solution in
H2O) was added to the reaction mixture and further heated
at 45 °C. Another 40 equiv of DABCO was added 1 h later.
The reaction mixture was further heated for another 3 h. Then,
2 M NH2OH,HCl in 0.1 M phosphate buffer, pH 6 (20-40 µL),
was added to the mixture, and the reaction was kept at room
temperature for a further 2 h. Purification and analyses of the
conjugates 28-31 were performed as for the derivatization
procedure.
Method B. Azide-containing oligosaccharides 26 and 27
were mixed with the phosphino-functionalized TT 22 in a 0.2
M phosphate buffer saline solution at a 12:1 molar ratio.
Reaction mixtures were heated at 47 °C for 6 h. The crude
reaction mixtures were then dialyzed against 0.1 M potassium
phosphate buffer saline, pH 7.4 (3 × 2 L over 2 days) at 4 °C,
and further purified by gel permeation chromatography on a
Sepharose CL-6B column (1 m × 160 mm) (Pharmacia Bio-
tech), using 0.1 M potassium phosphate buffer saline, pH 7.4
as eluent, at a flow rate of 0.2 mL.min-1, with optical density
at 280 nm and refractive index detection. The fractions
containing the conjugates were pooled and concentrated using
Vivaspin 15R centrifugal concentrators (Vivascience), having
a membrane cutoff of 10 000 Da, and at a centrifugal force of
5000g. The conjugates 32 and 33 were stored at 4 °C in the
presence of thimerosal (0.1 mg.mL-1) and assessed for total
carbohydrate27 and protein content.26
Derivatization of the Carbohydrate Haptens: Prepa-
ration of 25 and Derivatization of Pentasaccharide 3421
with N-Hydroxysuccinimidyl Ester 37. To a solution of 34
(10.5 mg, 13 µmol) in 0.2 M potassium phosphate buffer saline,
pH 7.3 (1 mL), was added 37 dissolved in CH3CN (50 µL), (3
× 26.9 mg, 3 × 130 µmol) in three portions at rt every 2 h.
After an additional period of 2 h, the crude reaction mixture
was concentrated under reduced pressure and the residue
purified by RP-HPLC (gradient: 0-5% B over 15 min). The
collected fractions were diluted with H2O, frozen, and freeze-
dried to give the corresponding activated pentasaccharide 25
as a white foam (8.5 mg, 70%): 1H NMR (400 MHz, D2O)
(selected data) δ 5.13 (d, 1 H, J ) 2.7 Hz), 5.00 (br s, 1 H),
4.90 (br s, 1 H), 4.73 (br s, 1 H), 4.48 (d, 1 H, J ) 8.6 Hz), 2.46
(t, 2 H, J ) 6.0 Hz), 1.92 (s, 3 H), 1.27 (d, 3 H, J ) 6.2 Hz),
1.24 (d, 3 H, J ) 6.0 Hz), 1.22 (d, 3 H, J ) 5.9 Hz); 13C NMR
(100 MHz, D2O) (selected data) δ 102.9, 101.5, 101.4, 101.0,
97.9, 81.8, 79.7, 79.4, 76.3, 72.9, 72.4, 72.3, 72.2, 71.7, 71.1,
70.4, 70.4, 70.1, 70.0, 69.7, 69.6, 69.3, 68.8, 68.5, 61.1, 61.0,
55.6, 47.6, 39.7, 35.4, 22.6, 18.2, 17.2, 17.0; positive FAB-MS
m/z 984 [M + Na]+; HRMS (FAB) calcd for [M + Na]+
984.3761, found 984.3777.
Preparation of cOmpounds 26 and 27: Derivatization
of pmLPS 35 with Succinimidyl Esters 39 and 41. To a
solution of 35 (1.5 to 3.6 µmol) in 0.2 M potassium phosphate
J. Org. Chem, Vol. 70, No. 18, 2005 7131